Position in NTRA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,275,630
+$2,078,590 QoQ
Shares Held
19,435
+21.6% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#260
of 844 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Focus Partners Wealth holds $898,220,753 across 20 Diagnostics & Research names. NTRA ranks #10 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
860,536 | $431,438,328 | |
| 2 | WAT |
Waters Corp /De/
|
485,602 | $182,120,174 | |
| 3 | DHR |
Danaher Corp /De/
|
725,093 | $138,115,714 | |
| 4 | DGX |
Quest Diagnostics Inc
|
163,327 | $34,617,157 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
61,904 | $32,588,741 | |
| 6 | A |
Agilent Technologies, Inc.
|
157,327 | $20,897,745 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
104,685 | $20,227,235 | |
| 8 | ILMN |
Illumina, Inc.
|
65,397 | $11,498,754 |
All Filings in NTRA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,275,630 | 19,435 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,197,040 | 15,986 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,935,766 | 17,180 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,978,160 | 12,289 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,254,886 | 7,428 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $847,470 | 5,993 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $873,657 | 5,519 | Shares | Sole | 2025-05-20 | |
| 2024-09-30 | $517,575 | 4,077 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||